Does AGALSIDASE BETA Cause Poor venous access? 71 Reports in FDA Database

Q: Does AGALSIDASE BETA cause Poor venous access?

71 reports of Poor venous access have been filed with the FDA for AGALSIDASE BETA, representing 1.1% of all AGALSIDASE BETA adverse event reports.

Q: How dangerous is Poor venous access from AGALSIDASE BETA?

Of 71 reports, 1 (1.4%) resulted in death and 19 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Poor venous access have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 1.1% of all adverse event reports for AGALSIDASE BETA.

Reports of Poor venous access with AGALSIDASE BETA

1.1%

of all AGALSIDASE BETA reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From AGALSIDASE BETA?

Of the 71 reports, 1 (1.4%) resulted in death, 19 (26.8%) required hospitalization.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 71 reports have been filed with the FAERS database.

What Other Side Effects Does AGALSIDASE BETA Cause?

Malaise (409) Pain (395) Pyrexia (362) Fatigue (338) Nausea (303) Weight decreased (272) Headache (269) Dyspnoea (266) Chills (259) Vomiting (244)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which AGALSIDASE BETA Alternatives Have Lower Poor venous access Risk?

AGALSIDASE BETA vs AGOMELATINE AGALSIDASE BETA vs ALAWAY AGALSIDASE BETA vs ALBENDAZOLE AGALSIDASE BETA vs ALBIGLUTIDE AGALSIDASE BETA vs ALBUMIN

AGALSIDASE BETA Full Profile All Poor venous access Reports All Drugs Causing Poor venous access AGALSIDASE BETA Demographics